Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA

Tracy L Diamond1, Frederic D Bushman

  • 1University of Pennsylvania School of Medicine, Department of Microbiology, 3610 Hamilton Walk, Philadelphia, PA 19104-6076, USA.

Journal of Virology
|November 25, 2005
PubMed

Insights

Human immunodeficiency virus integrase (IN) monomers have dual roles in DNA binding and catalysis. A single IN monomer performs both target DNA capture and integration, guiding inhibitor design.

Area of Science:

  • Molecular Biology
  • Virology
  • Biochemistry

Background:

  • Human immunodeficiency virus integrase (IN) is essential for viral replication, mediating the integration of viral cDNA into host cell DNA.
  • IN functions as a multimer, but the specific roles of individual monomers in DNA binding and catalysis remain largely uncharacterized.

Purpose of the Study:

  • To elucidate the functional distribution of target DNA capture and catalysis within the IN multimer.
  • To determine if distinct monomers are responsible for DNA binding versus catalytic activity.

Main Methods:

  • Utilized in vitro forced complementation assays with pairs of IN deletion derivatives to probe cis-trans relationships.
  • Analyzed effects of amino acid substitutions on catalysis and target site selection within complementing complexes.
  • Employed assay mixtures with three different IN genotypes to assess monomeric function.

Main Results:

  • Demonstrated that the IN variant contributing the active catalytic domain is also responsible for recognizing target DNA.
  • Established that a single IN monomer performs both target DNA capture and catalytic functions.
  • Identified specific ligands bound by the catalytically relevant IN monomer.

Conclusions:

  • A single IN monomer possesses dual functionality for both target DNA recognition and catalysis.
  • These findings provide critical insights into the mechanism of HIV integration.
  • The data can inform the development of more specific inhibitors targeting the IN active site.